TCT 2021 | Dasatinib prednisone induction prior to transplant for Ph+ ALL

Name: Dasatinib prednisone induction prior to transplant for Ph+ ALL
Uploaded: 2021-02-08T00:00:00Z
Duration: 1 min 48 s
Description: Marc Schwartz, MD, University of Colorado, Aurora, CO, discusses institutional outcomes of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) who have been treated with induction dasatinib prednisone prior to transplant. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.

Marc Schwartz • 8 Feb 2021

TCT 2021

Acute Lymphoblastic Leukemia Leukemia Dasatinib Prednisone

Marc Schwartz, MD, University of Colorado, Aurora, CO, discusses institutional outcomes of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) who have been treated with induction dasatinib prednisone prior to transplant. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.